TY - JOUR
TI - Cystic fibrosis drug approved for patients aged 6-11 years worked well in clinical practice
AU - Loukou, I.
AU - Petrocheilou, A.
AU - Moustaki, M.
AU - Katsagoni, C.N.
AU - Douros, K.
JO - Acta Paediatrica, International Journal of Paediatrics
PY - 2021
VL - 110
TODO - 1
SP - 228-229
PB - Wiley-Blackwell Publishing Ltd
SN - null
TODO - 10.1111/apa.15519
TODO - cystic fibrosis transmembrane conductance regulator;  ivacaftor plus lumacaftor;  cystic fibrosis transmembrane conductance regulator;  drug, Article;  body mass;  cataract;  child;  clinical article;  clinical practice;  cystic fibrosis;  drug efficacy;  drug safety;  drug withdrawal;  female;  follow up;  forced expiratory volume;  Greece;  human;  liver disease;  longitudinal study;  lung function;  male;  nutritional status;  observational study;  priority journal;  prospective study;  Pseudomonas infection;  spirometry, Child;  Cystic Fibrosis;  Cystic Fibrosis Transmembrane Conductance Regulator;  Humans;  Pharmaceutical Preparations
TODO - null
ER -